Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Continuous Activity Assay for HDAC11 Enabling Reevaluation of HDAC Inhibitors
Zsófia Kutil, Jana Mikešová, Matthes Zessin, et al.
ACS Omega (2019) Vol. 4, Iss. 22, pp. 19895-19904
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
Terence C. S. Ho, Alex H. Y. Chan, A. Ganesan
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 21, pp. 12460-12484
Open Access | Times Cited: 566
The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
Li Guo, Yuan Tian, Wei‐Guo Zhu
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 265
HDAC11: a rising star in epigenetics
Shanshan Liu, Fei Wu, Yuemei Jin, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110607-110607
Open Access | Times Cited: 90
Strategies To Design Selective Histone Deacetylase Inhibitors
Jelena Melesina, Conrad V. Simoben, Lucas Praetorius, et al.
ChemMedChem (2021) Vol. 16, Iss. 9, pp. 1336-1359
Closed Access | Times Cited: 84
Comparative Structure-Based Virtual Screening Utilizing Optimized AlphaFold Model Identifies Selective HDAC11 Inhibitor
Fady Baselious, Sebastian Hilscher, Dina Robaa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1358-1358
Open Access | Times Cited: 9
The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus
Saikat Dewanjee, V. Jayalakshmi, Rajkumar Singh Kalra, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1340-1340
Open Access | Times Cited: 50
HDAC11, an emerging therapeutic target for metabolic disorders
Huizhen Chen, Chunguang Xie, Qiu Chen, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 34
The Role of HDACs in the Response of Cancer Cells to Cellular Stress and the Potential for Therapeutic Intervention
Rahma K. Alseksek, Wafaa S. Ramadan, Ekram Saleh, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8141-8141
Open Access | Times Cited: 32
Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic Activity
Hany S. Ibrahim, Mohamed Abdelsalam, Yanira Zeyn, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 369-369
Open Access | Times Cited: 40
Comparative Structure Based Virtual Screening Utilizing Optimized AlphaFold Model Identifies Selective HDAC11 Inhibitor
Fady Baselious, Sebastian Hilscher, Dina Robaa, et al.
(2024)
Open Access | Times Cited: 5
Discovery of De Novo Macrocycle Inhibitors of Histone Deacetylase 11
Daniela Danková, Alexander L. Nielsen, Anne Zarda, et al.
JACS Au (2025) Vol. 5, Iss. 3, pp. 1299-1307
Open Access
Resolving the deceptive isoform and complex selectivity of HDAC1/2 inhibitors
N. Connor Payne, Ralph Mazitschek
Cell chemical biology (2022) Vol. 29, Iss. 7, pp. 1140-1152.e5
Open Access | Times Cited: 22
Development of Alkylated Hydrazides as Highly Potent and Selective Class I Histone Deacetylase Inhibitors with T cell Modulatory Properties
Ping Sun, Jing Wang, Khadija Shahed Khan, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 24, pp. 16313-16337
Open Access | Times Cited: 21
Comprehensive Mechanistic View of the Hydrolysis of Oxadiazole-Based Inhibitors by Histone Deacetylase 6 (HDAC6)
L. Motlova, Ivan Šnajdr, Zsófia Kutil, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 7, pp. 1594-1610
Open Access | Times Cited: 11
Lysine Fatty Acylation: Regulatory Enzymes, Research Tools, and Biological Function
Garrison Komaniecki, Hening Lin
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 20
Utilization of AlphaFold models for drug discovery: Feasibility and challenges. Histone deacetylase 11 as a case study
Fady Baselious, Dina Robaa, Wolfgang Sippl
Computers in Biology and Medicine (2023) Vol. 167, pp. 107700-107700
Open Access | Times Cited: 8
Selective Targeting of Epigenetic Readers and Histone Deacetylases in Autoimmune and Inflammatory Diseases: Recent Advances and Future Perspectives
Mohammed Ghiboub, Ahmed M I Elfiky, Menno P.J. de Winther, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 5, pp. 336-336
Open Access | Times Cited: 18
Utilization of an Optimized AlphaFold Protein Model for Structure-Based Design of a Selective HDAC11 Inhibitor with Anti-neuroblastoma Activity
Fady Baselious, Sebastian Hilscher, Sven Hagemann, et al.
(2024)
Open Access | Times Cited: 2
Unraveling HDAC11: Epigenetic orchestra in different diseases and structural insights for inhibitor design
Samima Khatun, Rinki Prasad Bhagat, Ritam Dutta, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116312-116312
Closed Access | Times Cited: 2
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia
Edurne San José‐Eneriz, Naroa Gimenez-Camino, Obdulia Rabal, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Utilization of an optimized AlphaFold protein model for structure‐based design of a selective HDAC11 inhibitor with anti‐neuroblastoma activity
Fady Baselious, Sebastian Hilscher, Sven Hagemann, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 10
Open Access | Times Cited: 2
Continuous Fluorescent Sirtuin Activity Assay Based on Fatty Acylated Lysines
Matthes Zessin, Marat Meleshin, Sebastian Hilscher, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7416-7416
Open Access | Times Cited: 5
The Emerging role of HDACs: Pathology and Therapeutic targets in Diabetes Mellitus
Saikat Dewanjee, V. Jayalakshmi, Pratik Chakraborty, et al.
(2021)
Open Access | Times Cited: 10
Continuous enzyme activity assay for high-throughput classification of histone deacetylase 8 inhibitors
Markus Schweipert, Anuja Amurthavasan, Franz‐Josef Meyer‐Almes
Exploration of Targeted Anti-tumor Therapy (2023), pp. 447-459
Open Access | Times Cited: 3
Continuous Sirtuin/HDAC (histone deacetylase) activity assay using thioamides as PET (Photoinduced Electron Transfer)–based fluorescence quencher
Matthes Zessin, Marat Meleshin, Zeljko Simic, et al.
Bioorganic Chemistry (2021) Vol. 117, pp. 105425-105425
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top